Hoberman Kenneth

Avg. Two Year Performance

(26%) Avg. Purchase Return
(12%) Compound
18% Avg. Sale Return
9% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return15%31%38%(17%)(26%)
Purchase Success Rate1 of 11 of 11 of 10 of 10 of 1
Average Sale Return3%(8%)9%11%18%
Sale Success Rate5 of 144 of 145 of 145 of 145 of 14
Drugs » Biotechnology

Chief Operating Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 264.94K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 103.14K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--